Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20161125001Phase 1Not yet recruiting
Phase 1, randomised, open-label trial of mosapride (2 arms), sponsored by International Bio Service. Primary endpoint: Rate and extent of absorption. Planned start Feb 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20161125001.